Health
Clover Biopharma’s new trimeric subunit vaccine candidate prevents COVID-19 in monkeys – News-Medical.Net
The vaccine candidate produced a high level of neutralizing antibodies in animal models. Rhesus macaques immunized with the vaccine candidate showed reduced viral loads in the lungs. The research is published on the preprint server bioRxiv.
Researchers from Clover Biopharmaceuticals, the Chinese Academy of Sciences, and China’s National Institutes for Food and Drug Control (NIFDC) report a trimeric subunit vaccine candidate similar to the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate produced a high level of neutralizing antibodies in animal models. Rhesus macaques immunized with the vaccine candidate showed reduced viral loads in the lungs. The research is published on the…
-
Business20 hours agoWhy is Alphabet stock worth less than Nvidia, Microsoft, Apple, and Amazon even though it is the most profitable S&P 500 company?
-
Noosa News19 hours ago‘Sunny, benign’ school holiday weather after morning showers in parts of Queensland
-
General14 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News16 hours agoTips to improve engagement – Proctor